Schistosoma mansoni in Brazil in 2015: retrieval of deaths and characteristics of patients that evolved to death

  • Helio Milani Pegado Universidade de Brasilia (UnB)
  • Gilmara Lima Nascimento Universidade de Brasília (UnB)
  • Maria Regina Fernandes de Oliveira Universidade de Brasília (UnB)
Palavras-chave: Schistosomiasis, Epidemiology, Mortality Registries, Mortality, Schistosoma mansoni

Resumo

Introduction: Schistosomiasis is a disease endemic in Brazil. We analyzed the death records from the Brazilian Mortality Information System with the aim of retrieving deaths due to schistosomiasis and describing the patients that evolved to death in Brazil in the year of 2015. Methods: We evaluated the death certificates for retrieving basic causes due to schistosomiasis, estimated the mortality rate and described the sociodemographic characteristics of patients. Result: To retrieve the basic cause, we analyzed 150 death certificates and we found 39 (26%). Of the 406 studied deaths, 111 (27.3%) occurred in people aged between 60 and 69 and 101 (24.9%) between 70 and 79. Regarding the educational level, 196 (62.4%) had not concluded the elementary school and 85 (27.1%) had never studied. As to race/skin color, 248 deaths (65.1%) occurred in black or pardo. Pernambuco registered more deaths, with 119 (29.3%). Alagoas was the state presenting the highest mortality rate, with 1.62/100,000 residents. As immediate causes of death, most of them, 118 (29.1%), occurred by hypovolemic shock. Conclusions: Deaths were more frequent in older ages, consistent with the disease chronic evolution, in people with lower educational level, and in subjects that reported themselves as black or pardo.

Referências

Centers for Disease Control and Prevention (CDC). Parasites – Schistosomiasis. Atlanta, November 7, 2012.

Ministério da Saúde (MS). Vigilância da Esquistossomose Mansoni: Diretrizes Técnicas. 4th ed. Brasília: MS; 2014. 142 p.

World Health Organization (WHO). Informal Consultation on Expanding Schistosomiasis Control in Africa. 1st ed. Geneva: WHO; 2010. 38p.

Vander Werf MJ, De Vlas SJ. Current estimated total number of individuals with morbidity and mortality due to Schistosomiasis Haematobium and S. Mansoni infection in Sub-Saharan Africa. Geneva: WHO; 2005. Available at: http://www.who.int/schistosomiasis/epidemiology/table/en/

Noya O, Katz N, Pointier JP, Theron A, Noya BA. Schistosomiasis in America. In: Franco-Paredes C, Santos-Preciato JI, editors. Neglected Tropical Diseases - Latin America and the Caribbean. 1st ed. Vienna: Springer; 2015. p. 11-43.

Gryseels B, Polman K, Clerinx J, Kestens L. Human Schistosomiasis. Lancet. 2006; 368:1106-18.

Rasia, ICRB, da Rosa AC, Rediss AN. A utilização dos sistemas de informação em uma instituição de saúde de Pelotas/RS. The journal of health.com. 2012; 8(2):32-42.

Souza FPC, Vitorino RR, Costa AP, Faria Júnior FC, Santana LA, Gomes AP. Esquistossomose mansônica: aspectos gerais, imunologia, patogênese e história natural. Rev Soc. Bra Clín Méd. 2011;9(4):300-7.

Ministério da Saúde (MS). Fundação Nacional de Saúde. Manual de Instruções para o Preenchimento da Declaração de Óbito. 3rd ed. Brasília: MS; 2001. 42p.

Messias KLM, Bispo-Junior JP, Pegado MFQ, Oliveira LC, Peixoto TG, Sales MAC et al. Qualidade da informação dos óbitos por causas externas em Fortaleza, Ceará, Brasil. Cien Saude Colet. 2016;21(4):1255-1267.

Mahmoud AAF. Schistosomiasis and Other Trematode Infections. In: Longo DL, Fauci A, Kasper D, Hauser S, Jameson JL, Loscalzo J, editors. Harrison's principles of internal medicine. 18th ed. New York: McGraw-Hill; 2013. p. 1752-1759.

Prata A. Esquistossomose mansoni. In: Veronese R, Focaccia R. Doenças infecciosas e parasitárias. 5th ed. Rio de Janeiro: Guanabara Koogan; 2015. p. 2015-2038.

El-Tonsy MM, Hussein HM, Helal Tl-S, Tawfik RA, Koriem KM. Human Schistosomiasis mansoni associated with hepatocellular carcinoma in Egypt: current perspective. J Parasit Dis. 2016;40(3):976-80.

Leite LA, Pimenta Filho AA, Martins da Fonseca CS, Santana dos Santos B, Ferreira ReC, Montenegro SM, et al. Hemostatic dysfunction is increased in patients with hepatosplenic schistosomiasis mansoni and advanced periportal fibrosis. PLoS Negl Trop Dis. 2013;7(7):e2314.

Lima KeM, Aires AeL, Lucena LR, Almeida TM, Albuquerque MC, Castro CM. [Factors influencing the bacterial translocation in mice with chronic schistosomiasis]. Acta Gastroenterol Latinoam. 2012;42(4):309-20.

Olveda DU, Inobaya M, Olveda RM, Vinluan ML, Ng SK, Weerakoon K, et al. Diagnosing schistosomiasis-induced liver morbidity: implications for global control. Int J Infect Dis. 2017;54:138-44.

Papamatheakis DG, Mocumbi AO, Kim NH, Mandel J. Schistosomiasis-associated pulmonary hypertension. Pulm Circ. 2014;4(4):596-611.

Sabry AlH, El-Aal AA, Mahmoud NS, Nabil Y, Aziz IZ. An Initial indication of predisposing risk of schistosoma mansoni infection for hepatocellular carcinoma. J Egypt Soc Parasitol. 2015;45(2):233-40.

Sinkala E, Kapulu MC, Besa E, Zyambo K, Chisoso NJ, Foster GR, et al. Hepatosplenic schistosomiasis is characterised by high blood markers of translocation, inflammation and fibrosis. Liver Int. 2016;36(1):145-50.

Toda KS, Kikuchi L, Chagas AL, Tanigawa RY, Paranaguá-Vezozzo DC, Pfiffer T, et al. Hepatocellular Carcinoma Related to Schistosoma mansoni Infection: Case Series and Literature Review. J Clin Transl Hepatol. 2015;3(4):260-4.

Barbosa CS, de Souza Gomes EC, Campos JV, de Oliveira FJ, da Silva Mesquita MC, de Oliveira EC, et al. Morbidity of mansoni schistosomiasis in Pernambuco-Brazil: Analysis on the temporal evolution of deaths, hospital admissions and severe clinical forms (1999-2014). Acta Trop. 2016;164:10-6.

Terra-Filho M, Mello MF, Lapa MS, Teixeira RH, Jatene FB. Clinical and haemodynamic evaluation of chronic thromboembolic pulmonary hypertension patients scheduled for pulmonary thromboendarterectomy: Is schistosomiasis hypertension an important confounding factor? Clinics. 2010;65(11):1155-60.

Abo-Salem ES, Ramadan MM. A huge thrombosed pulmonary artery aneurysm without pulmonary hypertension in a patient with hepatosplenic schistosomiasis. Am J Case Rep. 2015;16:140-5.

Fernandes CJ, Jardim CV, Hovnanian A, Hoette S, Morinaga LK, Souza R. Schistosomiasis and pulmonary hypertension. Expert Rev Respir Med. 2011;5(5):675-81.

Hübner MP, Layland LE, Hoerauf A. Helminths and their implication in sepsis - a new branch of their immunomodulatory behaviour? Pathog Dis. 2013;69(2):127-41.

Mendonça, FM, Drumond E, Cardoso AMP. Problemas no preenchimento da Declaração de Óbito. R. bras. Est. Pop. 2010; 27(2): 285-295.

Stuque CO, Cordeiro JA, Cury PM. Avaliação dos erros ou falhas de preenchimento dos atestados de óbito feitos pelos clínicos e pelos patologistas. J. Bras. Patol. Med. Lab. 2003; 39( 4 ): 361-364.

Nascimento G L ; De Oliveira MRF. Severe forms of schistosomiasis mansoni: epidemiologic and economic impact in Brazil, 2010. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2013; 108, 29-36.

Gazzinelli A, Velasquez-Melendez G, Crawford SB, LoVerde PT, Correa-Oliveira R, Kloos H. Socioeconomic Determinants of Schistosomiasis in a Poor Rural Area in Brazil. Acta tropica. 2006; 99(2-3):260-271.

Publicado
2019-11-26
Seção
ARTIGOS ORIGINAIS